The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women. Participants (N=80) will be randomized to (1) enhanced usual care (risk assessment + referral to nurse practitioner) or (2) decision support (enhanced usual care + decision aid). Assessments will take place at baseline (T0) and 1-month post-intervention (T1). The primary outcome is informed decisions about breast MRI at T1.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 74
Healthy Volunteers: f
View:

• female

• aged 18-74 years

• self-identifying as Black and/or Latina

• no personal history of breast cancer

• English- or Spanish-speaking

• having received a mammogram with normal results in the last 12 months

• ≥20% lifetime breast cancer risk per the NCI Breast Cancer Risk Assessment Tool (BCRAT)

Locations
United States
Washington, D.c.
Georgetown University
RECRUITING
Washington D.c.
Contact Information
Primary
Claire C. Conley, PhD
claire.conley@georgetown.edu
2026875086
Time Frame
Start Date: 2025-06-01
Estimated Completion Date: 2027-12
Participants
Target number of participants: 80
Treatments
Active_comparator: Enhanced Usual Care
Participants in this arm will be mailed a letter with their estimated lifetime risk for breast cancer per the NCI Breast Cancer Risk Assessment Tool (BCRAT), information about screening breast MRI, and instructions for contacting the nurse practitioner (NP) at the Ralph Lauren Center (RLC) with questions.
Experimental: Decision Support
Participants in this arm will receive the same letter as those in the Enhanced Usual Care arm. In addition, they will be sent the decision aid via mail or email (as preferred).
Related Therapeutic Areas
Sponsors
Leads: Georgetown University

This content was sourced from clinicaltrials.gov